Even we are constantly surprised by the healing benefits of hemp. While it is not approved by the FDA, CBD aka the non-psychoactive component in the cannabis plant is showing signs to kill the bacteria responsible for major diseases such as gonorrhea, meningitis, and legionnaires disease, which is a major breakthrough in the cause to classify this anti-drug.
Particularly Renewed Exciting
The research collaboration between The University of Queensland and Botanix Pharmaceuticals Limited could lead to the first new class of antibiotics for resistant bacteria in 60 years. There have been no new molecular classes of antibiotics for Gram-negative infections discovered and approved since the 1960s, and we can now consider designing new analogs of CBD within improved properties, which is exactly what we are trying to do every day at KM Relief.
The study showed that CBD was widely effective against a much larger number of Gram-positive bacteria than previously known, including antibiotic-resistant pathogens such as MRSA (methicillin-resistant Staphylococcus aureus) or 'golden staph'. According to Dr Blaskovich CBD/Hemp "kills bacteria by bursting their outer cell membranes, but we don't know yet exactly how it does that, and need to do further research.”
It’s Only Just Begun
The collaborative study has enabled the progress of a topical CBD formulation towards clinical trials for decolonization of MRSA before surgery. We, at KM Relief plan to monitor this scientific progression and alter our own methods accordingly, because we believe this plant to have many properties that science has only just started to unlock, and we are on the forefront of each technological breakthrough.
How We Help
With the expertise that has led to the discovery that how cannabidiol is delivered makes a huge difference in its effectiveness at killing bacteria, thus making modern life more livable is everything we stand for as a company and a community.